Table 1.
Sociodemographic description of male partners at baseline by quartile of total serum cholesterol concentrations, LIFE Study, 2005-2009.
| Characteristics: N (%) | Males Total cholesterol (mg/dL) |
|||||
|---|---|---|---|---|---|---|
|
| ||||||
| Overall | Q1: <167 118(24) |
Q2: 167-190 127(26) |
Q3: 191-216 123(25) |
Q4: >216 123(25) |
p-value | |
| Age, years; Mean (SD) | 31.8 (4.9) | 31.3(4.4) | 30.4(4.5) | 32.6(5.4) | 33.0(4.9) | <0.001 |
| BMI, kg/m2; Mean (SD) | 29.8 (5.6) | 29.1 (6.2) | 30.0(5.9) | 29.5(5.4) | 30.4(4.8) | 0.34 |
| Self-Identified Race/Ethnicity | ||||||
| Non-Hispanic White | 384 (78) | 100 (85) | 99 (78) | 101 (82) | 84 (68) | |
| Non-Hispanic Black | 23 (5) | 6 (5) | 6 (5) | 3 (2) | 8 (7) | 0.01 |
| Hispanic | 45 (9) | 2 (2) | 10 (8) | 14 (11) | 19 (15) | |
| Other | 39 (8) | 10 (8) | 12 (9) | 5 (4) | 12 (10) | |
| Education | ||||||
| < High School/Equivalent | 47 (10) | 7 (6) | 15 (12) | 11 (9) | 14 (11) | |
| Some College or Tech | 141 (29) | 32 (27) | 29 (23) | 44 (36) | 36 (29) | 0.22 |
| College Graduate or Higher | 303 (62) | 79 (67) | 83 (65) | 68 (55) | 73 (59) | |
| Baseline Serum Cotinine (ng/mL) | ||||||
| No exposure (0, 9.99) | 384 (78) | 90 (77) | 108 (85) | 98 (80) | 88 (72) | |
| Passive smoking (10, 99.99) | 22 (4) | 6 (5) | 3 (2) | 6 (5) | 7 (6) | 0.18 |
| Active smoking (100, 299.99) | 44 (9) | 11 (9) | 9 (7) | 6 (5) | 18 (15) | |
| Heavy smoking (300, 595.31) | 40 (8) | 10 (9) | 7 (6) | 13 (11) | 10 (8) | |
| Baseline Alcohol (per month) | ||||||
| < Once per month | 29 (7) | 9 (10) | 7 (6) | 5 (5) | 8 (8) | |
| Once per month | 39 (9) | 11 (12) | 9 (8) | 12 (11) | 7 (7) | |
| 2-3 days per month | 80 (19) | 15 (16) | 22 (20) | 22 (20) | 21 (20) | |
| Once a week | 104 (25) | 23 (24) | 28 (25) | 26 (24) | 27 (25) | 0.98 |
| 2-3 times per week | 127 (30) | 29 (31) | 32 (29) | 33 (30) | 33 (31) | |
| 4-6 times per week | 28 (7) | 4 (4) | 7 (6) | 9 (8) | 8 (8) | |
| Every day | 12 (3) | 3 (3) | 5 (5) | 2 (2) | 2 (2) | |
| Baseline Report of Participation in a Vigorous Exercise Program During the Last 12 Months |
207 (42) | 51(43) | 59 (46) | 53 (43) | 44 (36) | 0.37 |
| Any Use of Lipid Lowering Drugs During the Study Reported on the Daily Journals |
18 (4) | 8 (7) | 5 (4) | 3 (2) | 2 (2) | 0.16 |